Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | CCR1 | P32246 | 3/20 | 0.52 |
| ▸ | CCR5 | P51681 | 3/20 | 0.52 |
| ▸ | CCR8 | P51685 | 3/20 | 0.52 |
| ▸ | METAP1 | P53582 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.52 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.52 |
| ▸ | CBFB | Q13951 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16672906 | 0.82 | KDM4E (0.68) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL160064 | 0.82 | KDM4E (0.67) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL27980340 | 0.81 | KDM4E (0.45) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL5846133 | 0.81 | GRM5 (0.60) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL28180497 | 0.81 | KDM4E (0.54) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL5945969 | 0.81 | GRM5 (0.56) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL13799201 | 0.80 | KDM4E (0.55) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL21988535 | 0.80 | KDM4E (0.48) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL31400283 | 0.80 | KDM4E (0.48) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL14426234 | 0.80 | KDM4E (0.65) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103450283-B | One class complex of iridium and method for making thereof and the application at organic electroluminescence device | NANJING UNIVERSITY (CN) | 2015-10-14 | — | — | CN | disclosed |
| CN-103450283-A | Novel iridium complex and preparation method thereof as well as application thereof in organic electroluminescence device | NANJING UNIVERSITY OF TECHNOLOGY | 2013-12-18 | — | — | CN | disclosed |
| CN-1325503-C | Luminous organic intermetallic compound and luminous element | SANYO ELECTRIC CO (JP) | 2007-07-11 | — | — | CN | disclosed |
| US-7067202-B2 | Luminous efficiency and capable of emitting light of spectrum components of red or blue wavelength band; for use in organic electroluminescent device | SANYO ELECTRIC CO., LTD. (JP) | 2006-06-27 | — | — | US | disclosed |
| US-20030040627-A1 | Luminescent organometallic compound and light emitting device | SANYO ELECTRIC CO., LTD. (JP) | 2003-02-27 | — | — | US | disclosed |
| CN-1397559-A | Luminous organic intermetallic compound and luminous element | SANYO ELECTRIC CO (JP) | 2003-02-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040627-A1 | Luminescent organometallic compound and light emitting device | IK, CRY1, LBR | KDM4E 3641/4885LMNA 3413/4885CCR1 1165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.